Lo que hay que ver en Amsterdam

Se aproxima el congreso de la ESC de 2013 en Amsterdam y es interesante saber que habrá de nuevo.  El Dr. Keith Fox comenta los detalles para The Heart. Hot […]

Se aproxima el congreso de la ESC de 2013 en Amsterdam y es interesante saber que habrá de nuevo.  El Dr. Keith Fox comenta los detalles para The Heart.

Hot Line I: Late Breaking Trials on Thrombosis (September 1)

Chairpersons: Panagiotis VARDAS (Heraklion, GR), Keith FOX (Edinburgh, GB)

Treatment of venous thromboembolism, the Hokusai VTE study-Harry BULLER (Amsterdam, NL)

TASTE: Thrombus aspiration during ST-segment elevation myocardial infarction. A multicenter, prospective, registry based randomized clinical trial- Ole FROBERT (Orebro, SE)

TAO: Otamixaban in non-ST-segment elevation acute coronary syndrome patients undergoing a planned invasive strategy- Philippe Gabriel STEG (Paris Cedex, FR)

RE-ALIGN: Dabigatran in patients with a mechanical heart valve- Frans VAN DE WERF (Leuven, BE)

PARIS: Incidence and Impact of Dual Antiplatelet Therapy Cessation On Adverse Cardiac Events Following Percutaneous Coronary Intervention: Two-Year Results from the Patterns of Non-Adherence to Anti-Platelet Regimens In Stented Patients (PARIS) Study- Roxana MEHRAN (New York, US)

Hot Line II: Late Breaking Trials on Intervention and devices (September 1)

Chairpersons: Mariell JESSUP (Philadelphia, US), Fausto Jose PINTO (Lisbon, PT)

PRAMI: Preventive Angioplasty in Myocardial Infarction Trial- David WALD (London, GB)

ACCOAST: A Comparison of Prasugrel at the Time of Percutaneous Coronary Intervention or as Pre-treatment At the Time of Diagnosis in Patients with Non-ST-Elevation Myocardial Infarction- Gilles MONTALESCOT (Paris, FR)

DECAAF: Delayed Enhancement - MRI determinant of successful Catheter Ablation of Atrial Fibrillation (DECAAF): Analysis of post ablation scar and outcome- Nassir MARROUCHE (Salt Lake City, US)

PRAGUE 14: Perioperative ischemia versus perioperative bleeding in consecutive cardiac patients undergoing non-cardiac surgery- Petr WIDIMSKY (Prague, CZ)

LINC study: LINC - A multicenter randomized trial comparing a mechanical CPR algorithm using LUCAS vs. manual CPR in out-of-hospital cardiac arrest patients- Sten RUBERTSSON (Uppsala, SE)

IN-TIME Study - The Influence of Implant-Based Home Monitoring on the Clinical Management of Heart Failure Patients with an Impaired Left Ventricular Function-Gerhard HINDRICKS (Leipzig, DE)

Hot Line III: Late Breaking Trials on Risk factors and Diabetes (September 2)

Chairpersons: Jeroen BAX (Leiden, NL), John Gordon HAROLD (Los Angeles, US)

PURE: Contrasting associations between risk factor burden, CVD incidence and mortality in high, middle and low income countries- Salim YUSUF (Hamilton, CA)

EXAMINE: EXamination of CArdiovascular OutcoMes with AlogliptIN versus Standard of CarE in Patients with Type 2 Diabetes Mellitus and Acute Coronary Syndrome- William B WHITE (Farmington, US)

SAVOR-TIMI 53: Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus (SAVOR)-TIMI 53 Study- Deepak BHATT (Newton, US)

ASSURE: Effect of an Oral Agent Inducing Apo A-I Synthesis on Progression of Coronary Atherosclerosis: Results of the ASSURE Study- Stephen James NICHOLLS (Adelaide, AU)

COMPARE: Effect of losartan on aortic dilatation rate in adults with Marfan Syndrome- Barbara Jm MULDER (Amsterdam, NL)

Hot Line IV: Late Breaking Trials on Heart Failure and Acute Coronary Syndrome (September 3)

Chairpersons: Donna ARNETT (Birmingham, US), Michel KOMAJDA (Paris, FR)

Centenary of the Tour de France Group: Mortality of French Participants from the Tour de France 1947-2012- Xavier JOUVEN (Paris, FR)

ATOMIC-AHF: Acute Treatment with Omecamtiv Mecarbil to Increase Contractility in Acute Heart Failure: Results from ATOMIC-AHF- John R TEERLINK (San Francisco, US)

EchoCRT: EchoCRT: Echocardiography guided Cardiac Resynchronization Therapy in patients with narrow QRS- Frank RUSCHITZKA (Zurich, CH)

AQUARIUS: Effect of the Renin Inhibitor Aliskiren on Progression of Coronary Atherosclerosis: AQUARIUS Study Results- Stephen James NICHOLLS (Adelaide, AU)

BIC-8: Instant early rule-out using cardiac troponin and copeptin in low- to intermediate-risk patients with suspected ACS: A prospective, randomized multicenter study- Martin MOECKEL (Berlin, DE)

También se presentaran nuevos datos sobre: RELAX-AHF, PARTNER, Symplicity HTN-1, CHAMPION, RAFT y ORIGIN.

Esperamos poder "postear"  lo que sucede en Amsterdam la próxima semana.  Así que stay tune folks.

________________________________________________________

Para más información consultar esta entrada en The Heart, donde el Dr. Keith Fox explica con más detalle las novedades del próximo congreso de la ESC.

Primero visto en:  The Heart.

Comments Closed

Comments are closed. You will not be able to post a comment in this post.